This is by contrast to the poor prognosis of PCD with Yo, Hu or CV2/CRMP5-Abs suggesting different pathological mechanisms for each subtypes of paraneoplastic antibodies [34]. The gene discussed is CDR2; the disease is paraneoplastic neurologic syndrome.